FDA Authorizes Additional COVID-19 Vaccine Dose for Certain Immunocompromised Individuals

Print Friendly, PDF & Email

Members of the CRN’s Scientific Review Board have compiled articles for those interested in learning more about an additional COVID-19 vaccine for immunocompromised individuals. As always, reach out to your healthcare provider to discuss the best decision for you.

COVID-19 Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals [Aug 12, 2021] 

COVID-19 Vaccines for Moderately to Severely Immunocompromised People [Aug 18, 2021]

American Society of Transplantation: COVID-19 Vaccine FAQ Sheet [updated Aug 13, 2021]

Share: